Physician profile
Pankaj Gupta
NPI 1306880992
$2,546.13
in general payments reported to CMS, 2019-2025
14 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $729 · 2020: $140 · 2021: $371 · 2022: $323 · 2023: $470 · 2024: $402 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568 · Consulting Fee: $400 · Education: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.74 |
| Consulting Fee | $400.00 |
| Education | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $618.12 | 2019-2021 | |
| Aerin Medical INC. | $420.01 | 2023-2024 | |
| Smith+Nephew, INC. | $363.03 | 2019-2024 | Tula, Stravix |
| Optinose US, INC. | $258.87 | 2019-2025 | |
| Acclarent, INC | $234.41 | 2019-2024 | Acclarent Aera |
| Regeneron Healthcare Solutions, INC. | $205.25 | 2020-2024 | Dupixent |
| Abbott Laboratories | $199.11 | 2022 | |
| Stryker Corporation | $99.02 | 2019-2024 | Audion Et Dilation System, Xpress Loprofile, Scopis Ent |
| Ars Pharmaceuticals Operations, INC. | $40.60 | 2025 | Neffy |
| Karl Storz Endoscopy-America | $32.06 | 2025 | |
| Kaleo, INC. | $28.86 | 2019 | |
| Inspire Medical Systems, INC. | $16.98 | 2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $15.43 | 2021 | |
| Hikma Pharmaceuticals USA | $14.38 | 2024 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pankaj Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.